Ovid Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Ovid Therapeutics Inc. (OVID) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.99 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 4.99M shares, a 35.63% increase year-over-year.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 4.58M shares, a 28.86% increase year-over-year.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -6.75M shares, a 3475.03% decline year-over-year.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 3.68M shares, a 110.33% increase year-over-year.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.15M shares, a 11.64% decline from fiscal 2024.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.70M shares, a 54.70% increase from fiscal 2023.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 3.04M shares, a 33.60% decline from fiscal 2022.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.58M shares, a 123.65% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.99M shares 10-Q · filed 2026-08-13 | 9.56M shares derived: sum of 2 quarters · filed 2026-08-13 | 2.81M shares derived: sum of 3 quarters · filed 2026-08-13 | 6.49M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 4.58M shares 10-Q · filed 2026-05-12 | -2.17M shares derived: sum of 2 quarters · filed 2026-05-12 | 1.50M shares derived: sum of 3 quarters · filed 2026-05-12 | 5.18M shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | -6.75M shares derived: 10-K 12 month − 3 quarters · filed 2026-03-18 | -3.07M shares derived: sum of 2 quarters · filed 2026-03-18 | 601.75K shares derived: sum of 3 quarters · filed 2026-03-18 | 4.15M shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 3.68M shares 10-Q · filed 2025-11-12 | 7.35M shares derived: sum of 2 quarters · filed 2025-11-12 | 10.90M shares derived: sum of 3 quarters · filed 2025-11-12 | 11.10M shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-06-30 | 3.68M shares 10-Q · filed 2025-08-13 | 7.23M shares derived: sum of 2 quarters · filed 2025-08-13 | 7.43M shares derived: sum of 3 quarters · filed 2026-03-18 | 9.17M shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-03-31 | 3.55M shares 10-Q · filed 2025-05-13 | 3.75M shares derived: sum of 2 quarters · filed 2026-03-18 | 5.50M shares derived: sum of 3 quarters · filed 2026-03-18 | 5.58M shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-12-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 1.95M shares derived: sum of 2 quarters · filed 2026-03-18 | 2.03M shares derived: sum of 3 quarters · filed 2026-03-18 | 4.70M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 1.75M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 1.83M shares derived: sum of 2 quarters · filed 2024-11-12 | 4.50M shares 10-Q · filed 2024-11-12 | 4.53M shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-06-30 | 80.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 2.75M shares 10-Q · filed 2024-08-13 | 2.79M shares derived: sum of 3 quarters · filed 2025-03-11 | 2.79M shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-03-31 | 2.67M shares 10-Q · filed 2024-05-14 | 2.71M shares derived: sum of 2 quarters · filed 2025-03-11 | 2.71M shares derived: sum of 3 quarters · filed 2025-03-11 | 3.05M shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | 33.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 37.50K shares derived: sum of 2 quarters · filed 2025-03-11 | 377.50K shares derived: sum of 3 quarters · filed 2025-03-11 | 3.04M shares 10-K · filed 2025-03-11 |
| 2023-09-30 | 4.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 344.00K shares derived: sum of 2 quarters · filed 2023-11-03 | 3.00M shares 10-Q · filed 2023-11-03 | 3.02M shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2023-06-30 | 340.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 3.00M shares 10-Q · filed 2023-08-04 | 3.02M shares derived: sum of 3 quarters · filed 2024-03-08 | 3.28M shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2023-03-31 | 2.66M shares 10-Q · filed 2023-05-05 | 2.68M shares derived: sum of 2 quarters · filed 2024-03-08 | 2.94M shares derived: sum of 3 quarters · filed 2024-03-08 | 4.81M shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 279.29K shares derived: sum of 2 quarters · filed 2024-03-08 | 2.15M shares derived: sum of 3 quarters · filed 2024-03-08 | 4.58M shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 259.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 2.13M shares derived: sum of 2 quarters · filed 2022-11-08 | 4.56M shares 10-Q · filed 2022-11-08 | 5.04M shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-06-30 | 1.87M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 4.30M shares 10-Q · filed 2022-08-09 | 4.78M shares derived: sum of 3 quarters · filed 2023-03-13 | 5.34M shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-03-31 | 2.43M shares 10-Q · filed 2022-05-10 | 2.91M shares derived: sum of 2 quarters · filed 2023-03-13 | 3.47M shares derived: sum of 3 quarters · filed 2023-03-13 | 3.83M shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2021-12-31 | 483.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 1.04M shares derived: sum of 2 quarters · filed 2023-03-13 | 1.40M shares derived: sum of 3 quarters · filed 2023-03-13 | 2.05M shares 10-K · filed 2023-03-13 |
| 2021-09-30 | 555.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 918.75K shares derived: sum of 2 quarters · filed 2021-11-10 | 1.56M shares 10-Q · filed 2021-11-10 | 3.50M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-06-30 | 363.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 1.01M shares 10-Q · filed 2021-08-16 | 2.94M shares derived: sum of 3 quarters · filed 2022-03-15 | 3.46M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-03-31 | 643.60K shares 10-Q · filed 2021-05-13 | 2.58M shares derived: sum of 2 quarters · filed 2022-03-15 | 3.10M shares derived: sum of 3 quarters · filed 2022-03-15 | 3.70M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-12-31 | 1.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 2.46M shares derived: sum of 2 quarters · filed 2022-03-15 | 3.05M shares derived: sum of 3 quarters · filed 2022-03-15 | 3.58M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 519.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 1.12M shares derived: sum of 2 quarters · filed 2020-11-13 | 1.65M shares 10-Q · filed 2020-11-13 | 3.24M shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2020-06-30 | 596.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 1.13M shares 10-Q · filed 2020-08-10 | 2.72M shares derived: sum of 3 quarters · filed 2021-03-15 | 2.81M shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2020-03-31 | 530.30K shares 10-Q · filed 2020-05-07 | 2.12M shares derived: sum of 2 quarters · filed 2021-03-15 | 2.21M shares derived: sum of 3 quarters · filed 2021-03-15 | 2.62M shares derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-12-31 | 1.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 1.68M shares derived: sum of 2 quarters · filed 2021-03-15 | 2.09M shares derived: sum of 3 quarters · filed 2021-03-15 | 3.55M shares 10-K · filed 2021-03-15 |
| 2019-09-30 | 90.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 497.15K shares derived: sum of 2 quarters · filed 2019-11-08 | 1.96M shares 10-Q · filed 2019-11-08 | 2.04M shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | 406.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 1.87M shares 10-Q · filed 2019-08-07 | 1.95M shares derived: sum of 3 quarters · filed 2020-03-11 | 2.25M shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | 1.46M shares 10-Q · filed 2019-05-07 | 1.55M shares derived: sum of 2 quarters · filed 2020-03-11 | 1.84M shares derived: sum of 3 quarters · filed 2020-03-11 | 1.92M shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-12-31 | 88.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 382.85K shares derived: sum of 2 quarters · filed 2020-03-11 | 464.10K shares derived: sum of 3 quarters · filed 2020-03-11 | 1.44M shares 10-K · filed 2020-03-11 |
| 2018-09-30 | 294.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 376.10K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.35M shares 10-Q · filed 2018-11-08 | 1.39M shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | 81.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.06M shares 10-Q · filed 2018-08-09 | 1.09M shares derived: sum of 3 quarters · filed 2019-03-07 | 1.27M shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | 976.48K shares 10-Q · filed 2018-05-08 | 1.01M shares derived: sum of 2 quarters · filed 2019-03-07 | 1.18M shares derived: sum of 3 quarters · filed 2019-03-07 | 1.47M shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | 35.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 208.35K shares derived: sum of 2 quarters · filed 2019-03-07 | 493.00K shares derived: sum of 3 quarters · filed 2019-03-07 | 1.54M shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 173.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 457.65K shares derived: sum of 2 quarters · filed 2017-11-09 | 1.50M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 284.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 1.33M shares 10-Q · filed 2017-08-10 | ||
| 2017-03-31 | 1.05M shares 10-Q · filed 2017-06-13 | |||
| 2016-12-31 | 1.29M shares 10-K · filed 2018-03-29 | |||
| 2015-12-31 | 1.88M shares 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |